QIAGEN powered by
Know your biomarkers: How PRKD1 is linked to head and neck squamous cell carcinoma (HNSCC)

QIAGEN Digital Insights Tuesday, May 31, 2022

COSMIC v96 adds new oncogene that may be beneficial to diagnose HNSCC Head and neck cancers are a heterogeneous collection…

Scale your exome workflow with Dr. Atil Bisgin at ESHG 2022

QIAGEN Digital Insights Thursday, May 19, 2022

Have you reserved your in-person or virtual spot at the European Human Genetics Conference (ESHG) held June 11-14, 2022, in…

How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability

QIAGEN Digital Insights Monday, April 25, 2022

The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into the trove…

Accelerate your data science-driven drug discovery: Announcing QIAGEN Biomedical Knowledge Base

QIAGEN Digital Insights Monday, April 25, 2022

You need biomedical relationships knowledge for innovative data- and analytics-driven drug discovery. Yet this knowledge is locked in thousands of…

New Content Release: HGMD Professional 2022.1

QIAGEN Digital Insights Tuesday, March 29, 2022

More mutations, better annotations, confident classifications HGMD Professional 2022.1 is now available, expanding the world’s largest collection of human inherited disease…

Using knowledge graphs to drive drug discovery

QIAGEN Digital Insights Tuesday, March 29, 2022

Have you ever done a Google search to find a restaurant or look up what your favorite actor is up…

3 trends that promise to quietly revolutionize cancer research and diagnostics in 2022

QIAGEN Digital Insights Friday, March 4, 2022

Experts forecast this year’s cancer research advances In cancer research, the focus has shifted to precision medicine and much progress…

Bioinformatics workflows for routine analysis of many samples

QIAGEN Digital Insights Wednesday, February 2, 2022

Discover an easy way to get reproducible analyses, traceability of results and efficient bulk analysis with QIGEN CLC workflows. Stringing…

Digging for rare finds – two breast cancer publications to keep a watch for in V95

QIAGEN Digital Insights Tuesday, February 1, 2022

While the world showed its support for affected people during Breast Cancer Awareness Month, COSMIC’s expert curators were working hard…

Genomics analysis of wastewater for SARS-CoV-2 tracking

QIAGEN Digital Insights Wednesday, January 26, 2022

Did you know SARS-CoV-2 is shed in the feces of individuals with symptomatic or asymptomatic infection? Viral particles shed into…

Learn what’s new in the QIAGEN CLC Genomics version 22 (v22) release

QIAGEN Digital Insights Wednesday, January 26, 2022

We are excited to share with you news of the new QIAGEN CLC Genomics version 22, which offers you many…

New Features Available in QIAGEN Clinical Insight (QCI) Update

QIAGEN Digital Insights Friday, January 21, 2022

The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE…